Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N-AcetylCysteine as a Potential Treatment of Methamphetamine Dependence

NCT01063205 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT01063205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01063205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N-AcetylCysteine as a Potential Treatment of Methamphetamine Dependence
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2010
Completion date
July 31, 2011
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine abuse, methamphetamine dependence, substance abuse